GPCR - Structure Therapeutics Inc.

QQQ $ 616.17 $ 0.00 (0 %)

DIA $ 469.65 $ 0.00 (0 %)

SPY $ 676.09 $ 0.00 (0 %)

TLT $ 91.59 $ 0.00 (0 %)

GLD $ 378.88 $ 0.00 (0 %)

Previous Close

$ 26.56

Open

$ 26.85

Bid

$ 26.57 x 2

Ask

$ 27.70 x 15

Day's Range

-- - --

52 Week Range

$ 13.22 - $ 42.57

Volume

722,215

Average Volume

Market Cap

Beta (5Y Monthly)

$ 1.32

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	02-27-2025	12-31-2024	10-K
4	11-13-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	03-08-2024	12-31-2023	10-K
8	11-17-2023	09-30-2023	10-Q
9	08-10-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	03-30-2023	12-31-2022	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

FDA Launches Green List To Protect America...
09/05/2025 15:40:06

https://www.fda.gov/news-events/press-announcements/fda-launches-green-list-protect-americans-illegal-imported-glp-1-drug-ingre...

HC Wainwright & Co. Maintains Buy on Struc...
08/07/2025 15:45:32

HC Wainwright & Co. analyst Ananda Ghosh maintains Structure Therapeutics (NASDAQ:GPCR) with a Buy and lowers the price ...

Guggenheim Maintains Buy on Structure Ther...
08/07/2025 14:12:49

Guggenheim analyst Seamus Fernandez maintains Structure Therapeutics (NASDAQ:GPCR) with a Buy and lowers the price target fr...

eli-lillys-rare-weight-loss-data-miss-could-benefit-competitors

Eli Lilly's Rare Weight Loss Data Miss Cou...
08/07/2025 13:55:46

Eli Lilly's obesity drug data misses targets, boosting shares of Novo Nordisk, Viking, Structure, and Terns amid promising ...

JMP Securities Maintains Market Outperform...
08/07/2025 13:27:23

JMP Securities analyst Jonathan Wolleben maintains Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and lowers ...

Structure Therapeutics Inc Files For Mixed...
08/06/2025 21:43:14

-SEC Filing

Structure Therapeutics Q2 EPS $(0.36) Miss...
08/06/2025 21:00:14

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate...

Cantor Fitzgerald Reiterates Overweight on...
06/23/2025 14:32:44

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

JMP Securities Reiterates Market Outperfor...
06/23/2025 13:13:53

JMP Securities analyst Jonathan Wolleben reiterates Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and mainta...

Reported Friday, Structure Therapeutics Sh...
06/23/2025 09:02:27

HC Wainwright & Co. Maintains Buy on Struc...
05/12/2025 12:11:34

HC Wainwright & Co. analyst Andrew Fein maintains Structure Therapeutics (NASDAQ:GPCR) with a Buy and lowers the price t...

Citigroup Initiates Coverage On Structure ...
05/02/2025 13:21:03

Citigroup analyst Samantha Semenkow initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Buy rating and announc...

HC Wainwright & Co. Maintains Buy on Struc...
04/22/2025 10:17:04

HC Wainwright & Co. analyst Andrew Fein maintains Structure Therapeutics (NASDAQ:GPCR) with a Buy and maintains $80 pric...

uniqure-hertz-global-eli-lilly-and-other-big-stocks-moving-higher-on-thursday

uniQure, Hertz Global, Eli Lilly And Other...
04/17/2025 14:30:55

whats-going-on-with-viking-therapeutics-structure-therapeutics-stock-on-monday

What's Going On With Viking Therapeutics, ...
04/14/2025 14:49:19

Pfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid obesi...

Citizens Capital Markets Maintains Market ...
02/28/2025 15:48:16

Citizens Capital Markets analyst Jonathan Wolleben maintains Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform a...

William Blair Initiates Coverage On Struct...
02/28/2025 12:06:20

William Blair analyst Andy Hsieh initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Outperform rating.

Structure Therapeutics FY 2024 GAAP EPS $(...
02/27/2025 22:13:54

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate o...

Stifel Initiates Coverage On Structure The...
01/08/2025 10:09:12

Stifel analyst Annabel Samimy initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Buy rating and announces Pri...

viking-therapeutics-structure-therapeutics-positioned-as-key-pharma-partners-for-weight-loss-products-analyst

Viking Therapeutics, Structure Therapeutic...
01/06/2025 19:53:01

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive...